SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001651308-18-000003
Filing Date
2018-11-08
Accepted
2018-11-08 16:24:58
Documents
116
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q beigene2018q310-q.htm 10-Q 1773366
2 EXHIBIT 10.2 exhibit102-rsuagreementfor.htm EX-10.2 38560
3 EXHIBIT 31.1 exhibit311.htm EX-31.1 14137
4 EXHIBIT 31.2 exhibit312.htm EX-31.2 14161
5 EXHIBIT 32.1 exhibit321.htm EX-32.1 8144
  Complete submission text file 0001651308-18-000003.txt   8576409

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bgne-20180930.xml EX-101.INS 1663843
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20180930.xsd EX-101.SCH 78675
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20180930_cal.xml EX-101.CAL 123577
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20180930_def.xml EX-101.DEF 355935
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20180930_lab.xml EX-101.LAB 808052
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20180930_pre.xml EX-101.PRE 548972
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37686 | Film No.: 181170021
SIC: 2834 Pharmaceutical Preparations